Investing Profile

Jerel Davis

VCInvestor
Managing Director at Versant Ventures
Photo of Jerel Davis, Managing Partner at Versant Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
512 CONNECTIONS
cb
Versant Ventures Managing Partner
$100K - $5.0M
$1.5M
19
$102.2M
CompanyStageDateRound SizeTotal Raised
Borealis Biosciences
Series AAug 2024$150M
$150M
Firefly Bio
Series AFeb 2024$94M
$94M
Co-investors: Todd Foley (MPM Capital)
Tentarix Biotherapeutics
Series BSep 2023$35M
Series AOct 2021$50M
$85M
Co-investors: Paul Grayson (Versant Ventures), Marcos Milla (Samsara BioCapital), Allyson Tighe (Amplitude VC)
Santa Ana Bio
Series AFeb 2023$43M
$170M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Brendan Bulik-Sullivan (GV (Google Ventures)), Christine Borowski (Access Biotechnology), Peter Emtage (Versant Ventures), Shinichiro Fuse
Ventus Therapeutics
Series CFeb 2022$140M
Series BApr 2021$100M
Series AMay 2020$60M
$300M
Co-investors: Brendan Bulik-Sullivan (GV (Google Ventures))
Turnstone Biologics
Series DJul 2021$80M
Series BNov 2016$41M
Series AOct 2015$11M
$130M
Co-investors: Rishi Gupta (OrbiMed)
RayzeBio
Series CJun 2021$110M
Series BDec 2020$110M
Series AOct 2020$45M
$420M
Co-investors: Aaron Royston (venBio), bong koh (KohFounders), Maha Katabi (Sofinnova Investments), Bong Koh (Venrock)
Graphite Bio
Series BMar 2021$150M
Series ASep 2020$45M
$200M
Co-investors: Jake Simson (RA Capital), Carlo Rizzuto (Versant Ventures), Abe Bassan (Samsara BioCapital)
Managing Director Versant Ventures2011 - Present
Stanford University PhD
Pepperdine University BS